Yin Li

10PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 22, 2026
Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma.

|Mar 29, 2025
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma.

Canjun Li, Xin Wang, Lei Deng

|Jan 08, 2025
Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma.

Yafan Yang, Liyan Xue, Xiankai Chen

|Nov 15, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial.

Xin Wang, Xiaozheng Kang, Ruixiang Zhang

|Jul 02, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.

Jianjun Qin, Liyan Xue, Anlin Hao

|Feb 15, 2023
Comparison of neoadjuvant nab-paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma.

Yafan Yang, Haomiao Li, Xiankai Chen

Pageof 2

Frequent Collaborators

3 joint publications

Jianjun Qin

2 joint publications

Ruixiang Zhang

1 joint publications

Wenqun Xing

1 joint publications

Xiaofeng Guo